- Home
- ANVS vs ORMP Comparison
ANVS vs ORMP Comparison
Compare ANVS & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANVS
- ORMP
- Stock Information
- Founded
- ANVS 2008
- ORMP 2002
- Country
- ANVS United States
- ORMP United States
- Employees
- ANVS N/A
- ORMP N/A
- Industry
- ANVS Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- ANVS Health Care
- ORMP Health Care
- Exchange
- ANVS Nasdaq
- ORMP Nasdaq
- Market Cap
- ANVS 44.6M
- ORMP N/A
- IPO Year
- ANVS 2020
- ORMP N/A
- Fundamental
- Price
- ANVS $2.36
- ORMP $2.18
- Analyst Decision
- ANVS Strong Buy
- ORMP Hold
- Analyst Count
- ANVS 5
- ORMP 1
- Target Price
- ANVS $30.25
- ORMP N/A
- AVG Volume (30 Days)
- ANVS 485.7K
- ORMP 77.2K
- Earning Date
- ANVS 08-14-2025
- ORMP 08-15-2025
- Dividend Yield
- ANVS N/A
- ORMP N/A
- EPS Growth
- ANVS N/A
- ORMP N/A
- EPS
- ANVS N/A
- ORMP N/A
- Revenue
- ANVS N/A
- ORMP $2,000,000.00
- Revenue This Year
- ANVS N/A
- ORMP N/A
- Revenue Next Year
- ANVS N/A
- ORMP N/A
- P/E Ratio
- ANVS N/A
- ORMP N/A
- Revenue Growth
- ANVS N/A
- ORMP 196.74
- 52 Week Low
- ANVS $1.11
- ORMP $1.82
- 52 Week High
- ANVS $17.88
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- ANVS 48.29
- ORMP 49.72
- Support Level
- ANVS $2.05
- ORMP $2.10
- Resistance Level
- ANVS $3.18
- ORMP $2.25
- Average True Range (ATR)
- ANVS 0.26
- ORMP 0.09
- MACD
- ANVS -0.08
- ORMP 0.00
- Stochastic Oscillator
- ANVS 27.43
- ORMP 63.16
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.